C86.10
Hepatosplenic T-cell lymphoma not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Hepatosplenic T-cell lymphoma NOS
- Hepatosplenic T-cell lymphoma with failed remission
Medical Intelligence & Overview
Hepatosplenic T-cell lymphoma (HSTCL) is a rare and aggressive type of lymphoma that primarily affects the liver, spleen, and bone marrow. Classified under ICD-10 code C86.10, this condition involves malignant T-cells that invade these organs, leading to significant health challenges. When the disease does not respond to treatment and fails to achieve remission, it indicates a more advanced and resistant form, requiring careful management and ongoing medical attention.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting T-cell development and proliferation Chronic immunosuppressive therapy, such as post-transplant medication Underlying autoimmune conditions or infections that alter immune function Exposure to certain environmental toxins or chemicals Rare familial genetic predispositions
Key Symptoms: Persistent fever without clear infection Unexplained weight loss and fatigue Abdominal pain or discomfort, often in the upper right region Enlargement of the liver (hepatomegaly) and spleen (splenomegaly) Night sweats and general malaise Anemia leading to pallor and increased vulnerability to infections
Diagnostic & Treatment
Diagnosis Path: Blood tests to identify abnormal blood cell counts Imaging studies such as ultrasound, CT scans, or MRI to visualize liver and spleen enlargement Biopsy of affected tissues to analyze cell types and confirm malignancy Immunophenotyping using flow cytometry to identify specific T-cell markers Molecular tests to detect genetic mutations associated with the disease
Treatment Protocols: High-dose chemotherapy regimens, possibly followed by stem cell transplantation Targeted therapies aimed at specific genetic mutations or cell pathways Immunotherapy to boost the body's ability to fight cancer cells Palliative treatments to manage symptoms and improve quality of life Participation in clinical trials exploring novel therapies
Clinical Advice & FAQs
Billing Guidance
Is C86.10 a billable ICD-10 code?
Yes, C86.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C86.10?
Clinical documentation must specify the nature of Hepatosplenic T-cell lymphoma not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference